Beth Hoffman

Beth Hoffman

Company: Origami Therapeutics, Inc.

Job title: Chief Executive Officer

Seminars:

Panel: Navigating the 3D Tissue Modelling Landscape Focusing on Model Adoption & Current Regulatory Frameworks 9:00 am

Discussing the need for common benchmarks and standards to ensure comparability and reproducibility across different laboratories and research settings Sharing insights and experiences from industry leaders on best practices, to bring these technologies internally by making a business case Addressing the current regulatory landscape for accepting data from 3D tissue models in drug developmentRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.